India
In India, we offer one-stop solutions for clinical trial needs, including a global depot and advanced cold chain logistics with GDSP and GMP-certified, temperature-controlled infrastructure. Strategically located to ensure fast product availability, our facility in Mumbai supports cost-efficient operations for pharma, biotech companies, and CROs, aligning with local standards.
Capabilities
  • Zuellig Pharma has a global depot and cold chain logistics network with advanced temperature-controlled facilities and GDSP and GMP facilities.
  • Smart Sourcing Solution provides access to medicines and ancillaries, including controlled drugs.
  • Specialised cold chain solutions available for temperature-sensitive materials.
  • Strong Quality Management System (QMS) and operational excellence processes with a qualified team to offer CTSM services.
Opportunities
  • Clinical trial industry in India to grow at 8.2% per annum until 2030.
  • Consistent patient population and easy access to modern medical technology in India.
  • India offers a favorable currency exchange rate for pharma and biotech companies.
  • Major pharma and biotech companies and CROs operate in India, incorporating local models to meet country standards, making it a cost-efficient and profitable market.